Thomas R. Browne

4.0k citations

61 papers · 3.0k indexed · 1 hit paper · h-index 23

Impact in

Psychiatry and Mental health top 0.5%
- Epilepsy research and treatment
Pediatrics, Perinatology and Child Health top 0.5%
- Pharmacological Effects and Toxicity Studies
- Pharmaceutical studies and practices

Papers in

Psychiatry and Mental health 30
- Epilepsy research and treatment 30
Pharmaceutical Science 12
- Chemical Reactions and Isotopes 11

Co-authors: Jan Koch‐Weser J. Kiffin Penry Gregory L. Holmes Joseph F. Collins Wayne E. Crill Joyce A. Cramer James O McNamara David M. Treiman
Journals: The Journal of Clinical Pharmacology (19 papers)Neurology (9 papers)New England Journal of Medicine (7 papers)Epilepsia (4 papers)Clinical Neuropharmacology (3 papers)
Partner nations: United States Belgium Mexico

In The Last Decade

Thomas R. Browne

60 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Comparison of Carbamazepine, Phenobarbital, Phenytoin, and Primidone in Partial and Secondarily Generalized Tonic–Clonic Seizures 1985 · 853 citations

Peers

Countries citing papers authored by Thomas R. Browne

Since Specialization

Citations

This map shows the geographic impact of Thomas R. Browne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas R. Browne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas R. Browne more than expected).

Fields of papers citing papers by Thomas R. Browne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas R. Browne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas R. Browne. The network helps show where Thomas R. Browne may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas R. Browne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas R. Browne Line = papers co-authored together Thomas R. Browne links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Performance of Human Mass Balance Studies with Stable Isotope‐Labeled Drug and Continuous Flow‐Isotope Ratio Mass Spectrometry: A Progress Report The Journal of Clinical Pharmacology ·Thomas R. Browne, George Szabó, Alfred Ajami, David G. Browne	1998	11
2	Stable Isotope Techniques in Early Drug Development: An Economic Evaluation The Journal of Clinical Pharmacology ·Thomas R. Browne	1998	12
3	Fosphenytoin (Cerebyx) Clinical Neuropharmacology ·Thomas R. Browne	1997	27
4	Central levodopa metabolism in Parkinson's disease after administration of stable isotope—labeled levodopa Annals of Neurology ·Raymon Durso, James Evans, Mariele Kruppa, George Szabó, Barbara Evans, Joseph S. Handler, Dana Jennings, Thomas R. Browne	1997	5
5	Pharmacology and pharmacokinetics of fosphenytoin Neurology ·Thomas R. Browne, Alan R. Kugler, Michael A. Eldon	1996	100
6	Performance of Human Mass Balance/Metabolite Identification Studies Using Stable Isotope (¹³C, ¹⁵N) Labeling and Continuous‐Flow Isotope‐Ratio Mass Spectrometry as an Alternative to Radioactive Labeling Methods The Journal of Clinical Pharmacology ·Thomas R. Browne, George Szabó, Alfred Ajami, David A. Wagner	1993	14
7	Chronic benzodiazepine administration Biochemical Pharmacology ·Wendy R. Galpern, Lawrence G. Miller, David J. Greenblatt, George Szabó, Thomas R. Browne, Richard I. Shader	1991	14
8	Test Performance Characteristics of the Serum Phenytoin Concentration (SPC) Therapeutic Drug Monitoring ·Gerald E. Schumacher, Judith T. Barr, Thomas R. Browne, Joseph F. Collins	1991	10
9	Stable Isotopes in Clinical Pharmacokinetic Investigations Clinical Pharmacokinetics ·Thomas R. Browne	1990	29
10	New Pharmacokinetic Methods III. Two Simple Tests for “Deep Pool Effect” The Journal of Clinical Pharmacology ·Thomas R. Browne, David J. Greenblatt, Gerald E. Schumacher, George Szabó, James Evans, Barbara Evans	1990	6
11	New Pharmacokinetic Methods II: Determination of the Presence or Absence of Product Inhibition in Drugs with Nonlinear Pharmacokinetics The Journal of Clinical Pharmacology ·Thomas R. Browne, George Szabó, Simon Löbl, Gerald E. Schumacher, James Evans, Barbara Evans	1990	5
12	Simultaneous separation and determination (in serum) of phenytoin and carbamazepine and their deuterated analogues by high-performance liquid chromatography—ultraviolet detection for tracer studies Journal of Chromatography A ·Javier Sebastián, Hugh Muirhead, Robert J. Perchalski, Thomas R. Browne	1990	17
13	Simultaneous determination of p-hydroxylated and dihydrodiol metabolites of phenytoin in urine by high-performance liquid chromatography Journal of Chromatography A ·George Szabó, Hugh Muirhead, John P. KILBY, Thomas R. Browne	1990	16
14	A Pharmacokinetic Rationale for Three Times Daily Administration of Ethotoin (Peganone®) The Journal of Clinical Pharmacology ·Thomas R. Browne, George Szabó	1989	1
15	Comparative Efficacy of Antiepileptic Drugs Clinical Neuropharmacology ·Mohamad A. Mikati, Thomas R. Browne	1988	10
16	Estimation of the Elimination Half‐Life of a Drug at Any Serum Concentration When the K_m and V_max of the Drug Are Known: Calculations and Validation With Phenytoin The Journal of Clinical Pharmacology ·Thomas R. Browne, David J. Greenblatt, Thaynara dos Reis, Javier Sebastián, Barbara Evans, Gerald E. Schumacher	1987	3
17	Determination of the in Vivo K_m and V_max of a Drug With Tracer Studies The Journal of Clinical Pharmacology ·Thomas R. Browne, David J. Greenblatt, James Evans, Barbara Evans, George Szabó, Gerald E. Schumacher	1987	3
18	Stable Isotopes in Pharmacology Studies: Present and Future The Journal of Clinical Pharmacology ·Thomas R. Browne	1986	15
19	Pharmacokinetics: Dose‐Dependent Changes The Journal of Clinical Pharmacology ·Thomas R. Browne, David J. Greenblatt, James Evans, George Szabó, Barbara Evans, Gerald E. Schumacher	1986	9
20	Ethosuximide in the treatment of absence (petit mal) seizures Neurology ·Thomas R. Browne, Fritz E. Dreifuss, Paul Dyken, Chengwen Wo, J. Kiffin Penry, Sivapragasam Alagesan, B. G. White, Philip T. White	1975	94

About Thomas R. Browne

Thomas R. Browne is a scholar working on Psychiatry and Mental health, Pharmaceutical Science, Clinical Biochemistry, Pediatrics, Perinatology and Child Health and Anesthesiology and Pain Medicine, having authored 61 papers that have together received 3.0k indexed citations. Recurring topics across this work include Epilepsy research and treatment (30 papers), Pharmacological Effects and Toxicity Studies (27 papers), Metabolism and Genetic Disorders (11 papers), Chemical Reactions and Isotopes (11 papers), Neuroscience and Neuropharmacology Research (9 papers), Pharmaceutical studies and practices (9 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Anesthesia and Sedative Agents (6 papers). The work is most often cited by research in Psychiatry and Mental health (1.9k citations), Pediatrics, Perinatology and Child Health (1.7k citations), Cellular and Molecular Neuroscience (836 citations), Clinical Biochemistry (213 citations) and Neurology (270 citations). Thomas R. Browne has collaborated with scholars based in United States, Belgium and Mexico. Frequent co-authors include Jan Koch‐Weser, J. Kiffin Penry, Gregory L. Holmes, Joseph F. Collins, Wayne E. Crill, Joyce A. Cramer, James O McNamara, David M. Treiman, Charlotte B. McCutchen and N. Paul Rosenthal. Their work appears in journals such as The Journal of Clinical Pharmacology, Neurology, New England Journal of Medicine, Epilepsia and Clinical Neuropharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact